BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 16585563)

  • 1. Motif inference reveals optimal CTL epitopes presented by HLA class I alleles highly prevalent in southern Africa.
    Honeyborne I; Rathod A; Buchli R; Ramduth D; Moodley E; Rathnavalu P; Chetty S; Day C; Brander C; Hildebrand W; Walker BD; Kiepiela P; Goulder PJ
    J Immunol; 2006 Apr; 176(8):4699-705. PubMed ID: 16585563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HLA-A*26, HLA-B*4002, HLA-B*4006, and HLA-B*4801 alleles predispose to adult T cell leukemia: the limited recognition of HTLV type 1 tax peptide anchor motifs and epitopes to generate anti-HTLV type 1 tax CD8(+) cytotoxic T lymphocytes.
    Yashiki S; Fujiyoshi T; Arima N; Osame M; Yoshinaga M; Nagata Y; Tara M; Nomura K; Utsunomiya A; Hanada S; Tajima K; Sonoda S
    AIDS Res Hum Retroviruses; 2001 Jul; 17(11):1047-61. PubMed ID: 11485622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel and promiscuous CTL epitopes in conserved regions of Gag targeted by individuals with early subtype C HIV type 1 infection from southern Africa.
    Masemola AM; Mashishi TN; Khoury G; Bredell H; Paximadis M; Mathebula T; Barkhan D; Puren A; Vardas E; Colvin M; Zijenah L; Katzenstein D; Musonda R; Allen S; Kumwenda N; Taha T; Gray G; McIntyre J; Karim SA; Sheppard HW; Gray CM;
    J Immunol; 2004 Oct; 173(7):4607-17. PubMed ID: 15383595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Competition-based cellular peptide binding assays for 13 prevalent HLA class I alleles using fluorescein-labeled synthetic peptides.
    Kessler JH; Mommaas B; Mutis T; Huijbers I; Vissers D; Benckhuijsen WE; Schreuder GM; Offringa R; Goulmy E; Melief CJ; van der Burg SH; Drijfhout JW
    Hum Immunol; 2003 Feb; 64(2):245-55. PubMed ID: 12559627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive screening for human immunodeficiency virus type 1 subtype-specific CD8 cytotoxic T lymphocytes and definition of degenerate epitopes restricted by HLA-A0207 and -C(W)0304 alleles.
    Currier JR; deSouza M; Chanbancherd P; Bernstein W; Birx DL; Cox JH
    J Virol; 2002 May; 76(10):4971-86. PubMed ID: 11967314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Promiscuous CTL recognition of viral epitopes on multiple human leukocyte antigens: biological validation of the proposed HLA A24 supertype.
    Burrows SR; Elkington RA; Miles JJ; Green KJ; Walker S; Haryana SM; Moss DJ; Dunckley H; Burrows JM; Khanna R
    J Immunol; 2003 Aug; 171(3):1407-12. PubMed ID: 12874232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and characterization of multiple HLA-A24-restricted HIV-1 CTL epitopes: strong epitopes are derived from V regions of HIV-1.
    Ikeda-Moore Y; Tomiyama H; Miwa K; Oka S; Iwamoto A; Kaneko Y; Takiguchi M
    J Immunol; 1997 Dec; 159(12):6242-52. PubMed ID: 9550428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of HLA-A motifs in identification of potential CTL epitopes in human papillomavirus type 16 E6 and E7 proteins.
    Kast WM; Brandt RM; Sidney J; Drijfhout JW; Kubo RT; Grey HM; Melief CJ; Sette A
    J Immunol; 1994 Apr; 152(8):3904-12. PubMed ID: 7511661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of dominant optimal HLA-B60- and HLA-B61-restricted cytotoxic T-lymphocyte (CTL) epitopes: rapid characterization of CTL responses by enzyme-linked immunospot assay.
    Altfeld MA; Trocha A; Eldridge RL; Rosenberg ES; Phillips MN; Addo MM; Sekaly RP; Kalams SA; Burchett SA; McIntosh K; Walker BD; Goulder PJ
    J Virol; 2000 Sep; 74(18):8541-9. PubMed ID: 10954555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of HLA-B57-restricted human immunodeficiency virus type 1 Gag- and RT-specific cytotoxic T lymphocyte responses.
    Klein MR; van der Burg SH; Hovenkamp E; Holwerda AM; Drijfhout JW; Melief CJ; Miedema F
    J Gen Virol; 1998 Sep; 79 ( Pt 9)():2191-201. PubMed ID: 9747728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HLA-A1 and HLA-A3 T cell epitopes derived from influenza virus proteins predicted from peptide binding motifs.
    DiBrino M; Tsuchida T; Turner RV; Parker KC; Coligan JE; Biddison WE
    J Immunol; 1993 Dec; 151(11):5930-5. PubMed ID: 7504010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and characterization of HLA-A*3303-restricted, HIV type 1 Pol- and Gag-derived cytotoxic T cell epitopes.
    Hossain MS; Tomiyama H; Inagawa T; Ida S; Oka S; Takiguchi M
    AIDS Res Hum Retroviruses; 2003 Jun; 19(6):503-10. PubMed ID: 12882660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of highly conserved and broadly cross-reactive HIV type 1 cytotoxic T lymphocyte epitopes as candidate immunogens for inclusion in Mycobacterium bovis BCG-vectored HIV vaccines.
    Ferrari G; Kostyu DD; Cox J; Dawson DV; Flores J; Weinhold KJ; Osmanov S
    AIDS Res Hum Retroviruses; 2000 Sep; 16(14):1433-43. PubMed ID: 11018863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular analysis of presentation by HLA-A2.1 of a promiscuously binding V3 loop peptide from the HIV-envelope protein to human cytotoxic T lymphocytes.
    Alexander-Miller MA; Parker KC; Tsukui T; Pendleton CD; Coligan JE; Berzofsky JA
    Int Immunol; 1996 May; 8(5):641-9. PubMed ID: 8671651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HLA class I self peptides isolated from a T-cell leukemia reveal the allele-specific motif of HLA-B38.
    Colovai AI; Suciu-Foca N; Baiulescu GE; Harris PE
    Tissue Antigens; 1994 Aug; 44(2):65-72. PubMed ID: 7817380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Classification of A1- and A24-supertype molecules by analysis of their MHC-peptide binding repertoires.
    Sidney J; Southwood S; Sette A
    Immunogenetics; 2005 Jul; 57(6):393-408. PubMed ID: 16003466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CTL response to HIV type 1 subtype C is poorly predicted by known epitope motifs.
    Ngandu NG; Bredell H; Gray CM; Williamson C; Seoighe C;
    AIDS Res Hum Retroviruses; 2007 Aug; 23(8):1033-41. PubMed ID: 17725421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of HIV-1-derived cytotoxic T lymphocyte epitopes restricted by protective HLA-B alleles during the HIV-1 epidemic.
    Schellens IM; Navis M; van Deutekom HW; Boeser-Nunnink B; Berkhout B; Kootstra N; Miedema F; Keşmir C; Schuitemaker H; van Baarle D; Borghans JA
    AIDS; 2011 Sep; 25(14):1691-700. PubMed ID: 21681058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HLA supertypes contribute in HIV type 1 cytotoxic T lymphocyte epitope clustering in Nef and Gag proteins.
    Chakraborty S; Rahman T; Chakravorty R; Kuchta A; Rabby A; Sahiuzzaman M
    AIDS Res Hum Retroviruses; 2013 Feb; 29(2):270-8. PubMed ID: 23061377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An HLA class I peptide-binding assay based on competition for binding to class I molecules on intact human B cells. Identification of conserved HIV-1 polymerase peptides binding to HLA-A*0301.
    van der Burg SH; Ras E; Drijfhout JW; Benckhuijsen WE; Bremers AJ; Melief CJ; Kast WM
    Hum Immunol; 1995 Dec; 44(4):189-98. PubMed ID: 8770631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.